Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Clear all

475 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200016
200115
200218
200318
200420
200529
200624
200721
200827
200929
201027
201117
201229
201328
201421
201519
201615
201715
201810
201911
202013
20219
20227
20232
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed475

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals57
M.D. Anderson Cancer Center41
National Heart, Lung, and Blood Institute (NHLBI)22
Bristol-Myers Squibb19
Fred Hutchinson Cancer Center19
National Cancer Institute (NCI)19
Gruppo Italiano Malattie EMatologiche dell'Adulto11
Pfizer11
Masonic Cancer Center, University of Minnesota8
St. Jude Children's Research Hospital7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive475
Leukemia, Myeloid, Acute167
Precursor Cell Lymphoblastic Leukemia-Lymphoma167
Myelodysplastic Syndromes138
Leukemia121
Leukemia, Lymphocytic, Chronic, B-Cell93
Lymphoma, Non-Hodgkin84
Hodgkin Disease77
Multiple Myeloma69
Leukemia, Myeloid, Chronic-Phase65

Trials

Showing 1 to 25 of 475. Each trial links to its page on Pharma Observatory.

375 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.